Objective: Assess relationships between patient, hearing, and cochlear implant (CI)-related factors and second-side CI speech recognition outcomes in adults who are bilaterally implanted. Study Design: Retrospective review of a prospectively maintained CI database. Setting: Tertiary academic center. Patients: One hundred two adults receiving bilateral sequential or simultaneous CIs. Outcome Measures: Postimplantation consonant-nucleus-consonant (CNC) word and AzBio sentence scores at ≥12 months. Results: Of patient, hearing and CI-specific, factors examined only postimplantation speech recognition scores of the first CI were independently associated with speech recognition performance of the second CI on multivariable regression analysis (CNC: ß = 0.471[0.298, 0.644]; AzBio: ß = 0.602[0.417, 0.769]). First-side postoperative CNC scores explained 24.3% of variation in second CI postoperative CNC scores, while change in first CI AzBio scores explained 40.3% of variation in second CI AzBio scores. Based on established 95% confidence intervals, 75.2% (CNC) and 65.9% (AzBio) of patients score equivalent or better with their second CI compared to first CI performance. Age at implantation, duration of hearing loss, receiving simultaneous versus sequential CIs, and preoperative residual hearing (measured by pure-tone average and aided speech recognition scores) were not associated with 12 month speech recognition scores at 12 months. Conclusions: The degree of improvement in speech recognition from first CI may predict speech recognition with a second CI. This provides preliminary evidence-based expectations for patients considering a second CI. Counseling should be guarded given the remaining unexplained variability in outcomes. Nonetheless, these data may assist decision making when considering a second CI versus continued use of a hearing aid for an unimplanted ear. Level of Evidence: III Address correspondence and reprint requests to Theodore R. McRackan, M.D., MSCR, 135 Rutledge Ave, MSC 550, Charleston, SC 29425; E-mail: mcrackan@musc.edu; James Dornhoffer, M.D., Medical University of South Carolina, Charleston, SC; E-mail: dornhoff@musc.edu J.D. and Y.F.L. contributed equally to this work. This research was partially supported by funding from a K23 award from National Institutes of Health Grant Number K23DC016911, and a grant from the American Cochlear Implant Alliance. The authors disclose no conflicts of interest. Copyright © 2020 by Otology & Neurotology, Inc. Image copyright © 2010 Wolters Kluwer Health/Anatomical Chart Company
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,